Sehweil A M, McKillop J H, Milroy R, Sayed M A, Ziada G, Banham S W, Davidson K G, Ragib A, Omar Y T, Abdel-Dayem H M
Department of Nuclear Medicine, University of Kuwait.
Nucl Med Commun. 1990 Apr;11(4):263-9. doi: 10.1097/00006231-199004000-00002.
To evaluate 201Tl in the detection of the primary tumour, lymph node involvement and mediastinal spread we have studied a total of 188 patients with histologically proven lung cancer, breast cancer or malignant lymphoma. Ten patients with benign lung disease were also examined. Static images were performed 20 min after intravenous injection of 75 MBq of thallous (201Tl) chloride. The results were compared with those of standard staging procedures including CT scanning and mediastinal exploration. Thallium-201 imaging was highly sensitive in detecting the primary tumour (lung cancer 86%, breast carcinoma 100%, lymphoma 85%), but showed low sensitivity in detecting mediastinal spread or lymph node involvement. Thallium-201 uptake was also observed in active sarcoidosis (one case) and active TB (two cases). We conclude that 201Tl imaging is unlikely to have a clinically useful role in the diagnosis or staging of lung cancer, breast cancer or lymphoma.
为评估铊-201(201Tl)在检测原发性肿瘤、淋巴结受累及纵隔扩散方面的作用,我们共研究了188例经组织学证实为肺癌、乳腺癌或恶性淋巴瘤的患者。另外还检查了10例患有良性肺部疾病的患者。静脉注射75MBq氯化亚铊(201Tl)20分钟后进行静态图像采集。将结果与包括CT扫描和纵隔探查在内的标准分期检查结果进行比较。铊-201显像在检测原发性肿瘤方面具有高度敏感性(肺癌86%,乳腺癌100%,淋巴瘤85%),但在检测纵隔扩散或淋巴结受累方面敏感性较低。在活动性结节病(1例)和活动性肺结核(2例)中也观察到铊-201摄取。我们得出结论,铊-201显像在肺癌、乳腺癌或淋巴瘤的诊断或分期中不太可能发挥临床有用的作用。